Minerva Neurosciences (NERV) Shares Outstanding (2013 - 2026)

Minerva Neurosciences has reported Shares Outstanding for 14 years, with the latest figure at $43.8 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 526.9% year-over-year to $43.8 million; the trailing twelve-month figure through Mar 2026 stood at $43.8 million (up 526.9% YoY), and the FY2025 full-year result was $43.3 million, up 518.79% from the prior year.
• Shares Outstanding for Q1 2026 stood at $43.8 million, up from $43.3 million in the prior quarter.
• The five-year high for Shares Outstanding was $43.8 million in Q1 2026, with the low at $5.3 million in Q2 2022.
• Historically, Shares Outstanding has averaged $10.8 million across 5 years, with a median of $7.0 million in 2023.
• Annual changes were most pronounced in 2022 — Shares Outstanding declined 0.0% — and 2026, when it jumped 526.9%.
• Minerva Neurosciences' Shares Outstanding stood at $5.3 million in 2022, then soared by 30.96% to $7.0 million in 2023, then changed by 0.0% to $7.0 million in 2024, then surged by 518.79% to $43.3 million in 2025, then grew by 1.31% to $43.8 million in 2026.
• The last three Shares Outstanding figures came in at $43.8 million (Q1 2026), $43.3 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.